These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 79863)

  • 41. Serum high-density lipoproteins in peripheral vascular disease.
    Bradby GV; Valente AJ; Walton KW
    Lancet; 1978 Dec; 2(8103):1271-4. PubMed ID: 82779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial.
    Carlson LA; Olsson AG
    Lancet; 1979 Apr; 1(8121):869-70. PubMed ID: 86108
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug therapy of hyperlipidemias].
    Wolfram G
    Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract]   [Full Text] [Related]  

  • 45. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Dtsch Med Wochenschr; 1976 Sep; 101(39):1413-7. PubMed ID: 185036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on the serum lipoprotein composition in 50-year-old men. A suggestion of chemical criteria for diagnosis of hyperlipoproteinaemia type III (Broad-beta disease).
    Vessby B
    Clin Chim Acta; 1976 May; 69(1):29-42. PubMed ID: 178469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
    Nikkilä EA; Viikinkoski P; Valle M; Frick MH
    Br Med J (Clin Res Ed); 1984 Jul; 289(6439):220-3. PubMed ID: 6430414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Differentiation of VLDL subfraction in the diagnosis of type III hyperlipoproteinaemias (author's transl)].
    Vogelberg KH
    J Clin Chem Clin Biochem; 1977 Jul; 15(7):389-92. PubMed ID: 197199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipids during postmenopausal treatment with estradiol valerianate and ethinyl estradiol-preliminary communication.
    Wallentin L; Larsson-Cohn U
    Acta Obstet Gynecol Scand Suppl; 1977; 65():65-7. PubMed ID: 199038
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of 4 mg estradiol valerianate on serum lipids in newly oophorectomized women.
    Pystynen P; Pyykkö K; Jopkela H; Niemelä A; Saarikoski S
    Maturitas; 1980 Jul; 2(2):95-100. PubMed ID: 7207218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies in asymptomatic primary hyperlipidaemia II. Clinical findings.
    Olsson AG
    Acta Med Scand; 1975 Jun; 197(6):477-85. PubMed ID: 168737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences among hyperlipoproteinaemic subjects in the response of lipoprotein lipids to resin therapy.
    Miller NE; Nestel PJ
    Eur J Clin Invest; 1975 Jun; 5(3):241-7. PubMed ID: 1149783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Menopausal oestrogen therapy, serum lipoproteins, and ischaemic heart disease.
    Tikkanen MJ; Nikkila EA
    Lancet; 1981 Jun; 1(8233):1319. PubMed ID: 6112635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of oestrogen implants on high density lipoproteins and its subfractions in women in their pre-mature menopause.
    Brook JG; Aviram M; Oettinger M; Sharf M
    Maturitas; 1982 Dec; 4(4):257-65. PubMed ID: 7169961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects.
    Rössner S; Weiner L
    Eur J Clin Pharmacol; 1983; 24(5):573-7. PubMed ID: 6873132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia.
    Maebashi M; Kawamura N; Sato M; Imamura A; Yoshinaga K
    Lancet; 1978 Oct; 2(8094):805-7. PubMed ID: 81361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.
    Miller GJ; Miller NE
    Lancet; 1975 Jan; 1(7897):16-9. PubMed ID: 46338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.